Plasmablastic Myeloma Presenting with Nodular Liver Lesions: Rare but Important to Recognize

Abstract

Nodular liver lesions commonly represent solid tumour metastases. However, haematological neoplasms should also be considered as primary cause. Extramedullary infiltration of multiple myeloma with hepatic invasion at diagnosis is uncommon. We describe an unusual case of a woman presenting with multiple liver lesions initially suggesting disseminated solid tumour disease. She appeared to have widespread plasmablastic myeloma, an aggressive subtype of multiple myeloma, instead.

Keywords

• Multiple myeloma, plasmablastic myeloma, extramedullary, liver metastases, liver lesions

Plasmablastic Myeloma Presenting with Nodular Liver Lesions: Rare but Important to Recognize

Öz

Nodüler karaciğer lezyonları genellikle solid tümör metastazını gösterir. Bununla birlikte, hematolojik neoplazmalar bunların ana nedeni olarak kabul edilmelidir. Tanıda hepatik invazyonlu multipl miyelomun ekstrameduller infiltrasyonu oldukça nadirdir. Biz başlangıçta yaygın solid tümör hastalığı olan multipl karaciğer lezyonları ile başvuran bir kadın olgu sunulmaktadır. Olguda yaygın plazmablastik miyelom tutulumu mevcuttur

Anahtar Kelimeler

• Multipl myeloma, plazmoblastik miyeloma, ekstramedulla, karaciğer metastazı, karaciğer lezyonu

Kaynakça

1. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med 2011;364:1046-60.
2. Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC. Multiple myeloma. Lancet 2009;374:324-39.
3. Rajkumar SV, Fonseca R, Lacy MQ, et al. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. J Clin Oncol 1999;17:1551-7.
4. Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 2008;111:2521-6.
5. Damaj G, Mohty M, Vey N, et al. Features of extramed- ullary and extraosseous multiple myeloma: a report of 19 patients from a single center. Eur J Haematol 2004;73:402-6.
6. Oshima K, Kanda Y, Nannya Y, et al. Clinical and patho- logic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol 2001;67:1-5.
7. Patlas M, Khalili K, Dill-Macky MJ, Wilson SR. Spectrum of imaging findings in abdominal extraosseous myeloma. AJR Am J Roentgenol 2004;183:929-32.
8. Perez-Soler R, Esteban R, Allende E, Tornos Salomo C, Julia A, Guardia J. Liver involvement in multiple myelo- ma. Am J Hematol 1985;20:25-9.

9. Simmons MZ, Miller JA, Levine CD, Glucksman WJ, Wachsberg RH. Myelomatous involvement of the liv- er: unusual ultrasound appearance. J Clin Ultrasound 1997;25:145-8.
10. Wu XN, Zhao XY, Jia JD. Nodular liver lesions involving multiple myeloma: a case report and literature review. World J Gastroenterol 2009;15:1014-7.
11. Kapadia SB. Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore) 1980;59:380-92.
12. Talamo G, Cavallo F, Zangari M, et al. Clinical and biologi- cal features of multiple myeloma involving the gastroin- testinal system. Haematologica 2006;91:964-7.
13. Thiruvengadam R, Penetrante RB, Goolsby HJ, Silk YN, Bernstein ZP. Multiple myeloma presenting as space-occu- pying lesions of the liver. Cancer 1990;65:2784-6.
14. Yoon YS, Min YH, Chon CY, et al. Liver involvement in mul- tiple myeloma proven by peritoneoscopy--a case report. Yonsei Med J 1993;34:90-7.
15. Heckmann M, Uder M, Grgic A, Adrian N, Bautz W, Heinrich M. Extraosseous manifestation of multiple myeloma with unusual appearance in computed tomography--case re- port. Rontgenpraxis 2008;56:249-53.
16. Greipp PR, Raymond NM, Kyle RA, O'Fallon WM. Multiple myeloma: significance of plasmablastic subtype in mor- phological classification. Blood 1985;65:305-10.
17. Albarracin F, Fonseca R. Plasma cell leukemia. Blood Rev 2011;25:107-12.